Haemonetics Corporation
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, inc…
Medical - Instruments & Supplies
US, Boston [HQ]
HAE/Financials
Wall Street · Earnings · Institutional Sentiment
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Haemonetics Corporation's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | 0.6800 | 2.010 | 938 | 909 | 35 | 34 | 47 | 116 | 47 | 47 | 366 | 351 |
| 2015 | 0.3300 | 1.899 | 910 | 922 | 16 | 31 | 40 | 132 | 40 | 43 | 339 | 355 |
| 2016 | -1.0900 | 1.727 | 909 | 911 | -55 | -49 | 126 | 60 | 36 | -25 | 323 | 301 |
| 2017 | -0.5100 | 1.517 | 886 | 876 | -26 | 6 | 128 | 110 | 39 | 21 | 301 | 304 |
| 2018 | 0.8600 | 1.868 | 903 | 898 | 45 | -18 | 145 | 44 | 56 | -19 | 316 | 257 |
| 2019 | 1.0700 | 2.334 | 967 | 968 | 55 | 44 | 192 | 158 | 83 | 68 | 298 | 265 |
| 2020 | 1.5100 | 3.343 | 988 | 995 | 76 | 63 | 264 | 167 | 153 | 80 | 299 | 234 |
| 2021 | 1.5700 | 2.563 | 870 | 868 | 79 | 89 | 142 | 194 | 57 | 114 | 274 | 255 |
| 2022 | 0.8500 | 2.532 | 993 | 986 | 43 | -3 | 169 | 139 | 71 | 30 | 339 | 313 |
| 2023 | 2.2700 | 2.967 | 1,168 | 1,154 | 115 | 43 | 249 | 215 | 156 | 106 | 376 | 329 |
| 2024 | - | 3.959 | - | 1,295 | - | 114 | - | 237 | - | 117 | - | 362 |
| 2025 | - | 4.592 | - | 1,396 | - | 236 | - | 292 | - | 164 | - | 447 |
| 2026 | - | 5.410 | - | 1,471 | - | 2.F12X | - | 2.F121 | - | 2.F1211 | - | 2.F1211 |
| 2027 | - | 6.282 | - | 1,599 | - | 1.F13X | - | 1.F131 | - | 1.F1311 | - | 1.F1311 |
| 2028 | - | 8.540 | - | 1,937 | - | 0.F14X | - | 0.F141 | - | 0.F1411 | - | 0.F1411 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Citigroup
1Y Ago:
Equal-Weight
Prev. Grade
Equal-Weight
Nov. 6, 2024
Equal-Weight
Overall Consensus
Grading Consensus
Price Target Consensus
-23.067% $20.58 · MISS
Nov. 6, 2024Price Then
$74.98
Price Target
$109.80
Price Now
$89.22